<DOC>
	<DOC>NCT00479414</DOC>
	<brief_summary>To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting</brief_summary>
	<brief_title>Lilly's Emotional and Physical Symptoms of Depression Study</brief_title>
	<detailed_description>To assess physical and emotional symptoms of depressed patients</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Meet criteria for major depressive disorder according to the DSMIV diagnostic criteria Outpatients at least 18 years of age Sign the informed consent All females must test negative for a urine pregnancy test at visit 1. Females of child bearing potential must agree to utilize medically acceptable and reliable means of birth control Have a level of understanding sufficient to communicate with the investigator and are able to complete all patient selfrated scales in the study Are investigator site personnel directly affiliated with the study or immediate family. Are employed by Eli Lilly and Company Have received treatment within the last 30 days or are currently enrolled in a study with a drug that has not received regulatory approval for any indication at time of study entry Current substance dependence, excluding nicotine and caffeine Treatment with a monoamine oxidase inhibitor within 14 days prior to Visit 1 or potential need to use an MAOI within 5 days after discontinuation of study drug Acute live injury or severe (ChildPugh Class C) cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>